Checkpoint Blockade + Chemotherapy: the Right Combination for AML?
Blood cancer discovery(2021)
Abstract
An emerging strategy to enhance the efficacy of immune checkpoint blockade in relapsed/refractory cancers is increasing immunogenic cell death via combination with cytotoxic therapies. Understanding the effects of cytotoxic and immunotherapeutic agents on immune cell populations will enable improved mechanism-based design of combination therapies to maximum efficacy and minimum toxicity.
See related article by Zeidner et al., p. 616
MoreTranslated text
Key words
chemotherapy,aml
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined